Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of sustained-release sirolimus ophthalmic preparation

A technology of sirolimus and eye drops, which is applied in the direction of aerosol delivery, sensory diseases, and pharmaceutical formulations, etc., can solve problems such as difficulty and difficulty of sirolimus, achieve less toxic and side effects, increase compliance, increase The effect of treatment success

Active Publication Date: 2014-10-15
GUANGDONG WHOLEWIN TECH
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, sirolimus is insoluble in water and is easily degraded in aqueous solution, making it difficult to make a sirolimus that is convenient for clinical use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of sustained-release sirolimus ophthalmic preparation
  • A kind of sustained-release sirolimus ophthalmic preparation
  • A kind of sustained-release sirolimus ophthalmic preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-3

[0020] Example 1-3 Components and dosage of raw materials for preparing sustained-release sirolimus eye drops

[0021]

[0022] The bletilla striata polysaccharide gum can be obtained from commercial products or by alcohol-water extraction method: first extract the bletilla striata raw material with 80% ethanol for 5 hours, recover the ethanol from the dregs and extract it with waste water for 3 times, and concentrate the extract under reduced pressure for alcohol extraction. Recover the polysaccharide. The purity of crude bletilla striata polysaccharide gum is generally lower than 80%, the color is slightly yellow, and it has a medicinal smell. It needs to be refined for medicinal purposes. Generally, multiple precipitations with ethanol, washing with ether and acetone organic solvents are used to improve its purity. Ethanol precipitation combined with solvent washing can make the purity of Bletilla striata polysaccharide gum reach 90%-95%. Further improving the p...

Embodiment 4-6

[0025] Example 4-6 Preparation of slow-release sirolimus ophthalmic gel raw material components and dosage

[0026]

[0027] According to the technical scheme of the present invention, the kinds of auxiliary materials that can be selected for preparing sirolimus ophthalmic gel are not limited to the varieties listed in the above table, and the following multiple options can also be selected:

[0028] Wherein, the kind selection and consumption of antibacterial agent are the same as embodiment 1~3.

[0029] The dosage ratio of the thickener to sirolimus is 0.5-5.0:1.0.

[0030] The preparation method is as follows: dissolve the whole amount of sirolimus with bletilla striata polysaccharide glue, dissolve the thickener with water for injection to disperse and let it cool, and then dissolve the pH regulator and bacteriostatic agent with water for injection, and then add the thickener that has been dissolved and sirolimus, supplemented with water for injection to the requi...

Embodiment 7-9

[0031] Example 7-9 Preparation of sustained-release sirolimus ophthalmic ointment raw material components and dosage

[0032] Raw material species Example 7 Example 8 Example 9 Sirolimus 0.2 grams 0.5 grams 1.0g Bletilla striata polysaccharide gum 1 g 2.0 grams 0.5 grams Anhydrous lanolin 10 grams 15 grams 12 grams liquid paraffin 2 grams 8 grams 6 grams Yellow Vaseline 88 grams 76 grams 81 grams Pharmacy specification 0.2% sirolimus eye ointment 0.5% sirolimus eye ointment 1% sirolimus eye ointment

[0033] Preparation method: Dissolve the whole amount of sirolimus with Bletilla striata polysaccharide gum, add appropriate amount of sterilized and cooled liquid paraffin, grind it into a fine paste, pass through a 200-mesh sieve, and then gradually add sterile and filtered lanolin and yellow petrolatum Mixture, mix well, that is. All preparation equipment and packaging containers used must...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is a sustained-release sirolimus ophthalmic preparation for external use in ophthalmology, which uses sirolimus as a medicinal raw material, Bletilla striata polysaccharide gum as a sustained-release agent, and is prepared with appropriate auxiliary materials. The dosage of Bletilla striata polysaccharide gum is : Sirolimus: Bletilla striata polysaccharide gum = 1.0: 0.5-5.0. The present invention uses Bletilla striata polysaccharide glue as a mucoadhesive polymer drug delivery system, solves the problem of poor solubility and stability of sirolimus in a simple aqueous solution, and uses Bletilla striata to converge, stop bleeding, clear away heat and dampness, reduce swelling and promote muscle growth Efficacy, enhance the immunosuppressive effect and ocular tissue penetration of sirolimus.

Description

technical field [0001] The present invention relates to medical preparations, in particular to topical eye preparations for treating ophthalmic diseases. Background technique [0002] Sirolimus (SRL), namely rapamycin, is a macrolide antibiotic produced by Streptomyces hygroscopicus, which is effective against various non-T cells, such as B cells, macrophages, It plays a role in the proliferation of cells such as granulocytes and endothelial cells, as well as in cell function. Clinical trials have shown that sirolimus has a significant immunosuppressive effect on organ transplant patients. [0003] In contemporary ophthalmology, moderate to severe intraocular inflammation, especially ophthalmic autoimmune diseases such as uveitis, urgently needs effective immunosuppressants. Studies have found that FK506-binding protein (FKBP) is highly expressed in corneal and retinal tissues, suggesting the potential value of sirolimus for ocular immunosuppression. [0004] For ocular d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/08A61K9/06A61K31/436A61K31/715A61K47/36A61P27/02A61P37/02A61P37/06
Inventor 王延东吴绮峰
Owner GUANGDONG WHOLEWIN TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com